avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxo6
|
ENSMUSG00000052135.8 | forkhead box O6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxo6 | mm10_v2_chr4_-_120287349_120287349 | 0.61 | 8.1e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
1.3 | 6.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 8.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.0 | 3.0 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.0 | 3.0 | GO:0071846 | actin filament debranching(GO:0071846) |
0.9 | 2.6 | GO:1900157 | regulation of fermentation(GO:0043465) regulation of bone mineralization involved in bone maturation(GO:1900157) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.8 | 2.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.7 | 3.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 7.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 2.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 3.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 2.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 1.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 2.0 | GO:1903336 | endosome localization(GO:0032439) negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.2 | GO:0070358 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.7 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.3 | 1.0 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.2 | 1.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.0 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 1.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 1.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 2.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 10.1 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 2.2 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 2.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 6.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 1.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 1.8 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 4.1 | GO:0050821 | protein stabilization(GO:0050821) |
0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.9 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 13.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 3.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 4.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 3.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.5 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.2 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.9 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 1.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 8.4 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 10.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 2.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 3.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 5.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 1.9 | GO:0005814 | centriole(GO:0005814) |
0.0 | 2.6 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 6.4 | GO:0031012 | extracellular matrix(GO:0031012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.9 | 2.6 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.6 | 2.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 8.5 | GO:0019841 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.4 | 2.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 3.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 2.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 2.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 3.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 13.4 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 0.5 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.2 | 1.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 7.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 10.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 1.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 2.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 1.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 2.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 3.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 3.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 2.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 14.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 7.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 4.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 7.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 6.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 4.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 8.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 2.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |